Advertisement

Topics

U.K. Drug Developer Opens First U.S. Base In Metro Boston

14:00 EST 9 Nov 2017 | Pharmaceutical Processing

RxCelerate is an outsourced drug discovery and development company, founded in Cambridge, U.K. in 2012. The new U.S. operation is led by Laura Hamilton, who joined the company from the local industry trade association, MassBio.
Staff Author: 

Original Article: U.K. Drug Developer Opens First U.S. Base In Metro Boston

NEXT ARTICLE

More From BioPortfolio on "U.K. Drug Developer Opens First U.S. Base In Metro Boston"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...